Date

Friday, July 15, 2022

Venue

Time

10:00 (GMT+7)

Agenda

AGMS

1. The Annual Report regarding the condition and operation of the company in the financial year 2021, including the Board of Commissioners Oversight Report of the financial year 2021, and ratification of the company's Financial Statements of the financial year 2021; and to release and discharge of all responsibilities (volledig acquit et de charge) to all Board members for the management and supervision carried out in the financial year 2021.
2. Determination on the use of the company net profit of the financial year 2021.
3. Determination of salary/honorarium along with facilities and allowances in the financial year 2022 for Board of Directors and Board of Commissioners.
4. Election of a Public Accountant Firm to audit the company Financial Report of the financial year 2022.
5. Proceeds usage report from MESOP.
6. Proceeds usage report from the public offering I, Shelf Registration Bonds, and SUKUK phase II.

 EGMS

1. Approval of the adjustment of the company's purpose and objectives to the KBLI 2020, and amendments to the company's Articles of Association related to this agenda.
2. Approval of changes to the composition of the Company's management and thereby making changes to the Company's Articles of Association related to this agenda
3. Approval of the increase in the company's Paid-in and Issued Capital, as a result of MESOP.
4. Delegation of authority to Board of Commissioners to state in a separate notarial deed regarding the realization of the new shares issuance in MESOP, and amending the article 4 of the company's Articles of Association.
5. Delegation of authority to Board of Directors with the approval of Board of Commissioners to add financing facilities and pledge/guarantee company assets for business expansion.